P3 Health Partners (NASDAQ:PIII) Issues Quarterly Earnings Results

P3 Health Partners (NASDAQ:PIII) released its earnings results on Thursday. The company reported ($23.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.06) by ($14.96), FiscalAI reports. P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. The company had revenue of $384.81 million during the quarter, compared to analysts’ expectations of $357.65 million.

P3 Health Partners Stock Performance

P3 Health Partners stock traded down $0.32 during mid-day trading on Thursday, reaching $2.79. The company’s stock had a trading volume of 34,425 shares, compared to its average volume of 89,459. P3 Health Partners has a 12-month low of $1.52 and a 12-month high of $11.30. The company has a market capitalization of $20.12 million, a P/E ratio of -0.07 and a beta of 0.86. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.32 and a current ratio of 0.32. The firm’s fifty day moving average price is $2.48 and its two-hundred day moving average price is $5.25.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. BTIG Research reissued a “neutral” rating on shares of P3 Health Partners in a report on Friday, December 12th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $12.50.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.